Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Fish and Richardson
Moodys
Baxter
Covington
Harvard Business School
Chinese Patent Office
Boehringer Ingelheim

Generated: November 15, 2018

DrugPatentWatch Database Preview

Interferon alfa-n3 - Biologic Drug Details

« Back to Dashboard

Summary for interferon alfa-n3
Tradenames:1
Patents:19
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for interferon alfa-n3
Ingredient-typeInterferon-alpha

US Patents for interferon alfa-n3

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Schering Corporation (Kenilworth, NJ) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Warner-Lambert Company (Morris Plains, NJ) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Warner Lambert Company (Morris Plains, NJ) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Warner-Lambert Company (Morris Plains, NJ) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Warner-Lambert Company (Morris Plains, NJ) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Bayer Healthcare LLC (Tarrytown, NY) ➤ Try a Free Trial RX search
Interferon Sciences ALFERON N INJECTION interferon alfa-n3 VIAL 103158 001 1989-10-10 ➤ Try a Free Trial Bayer Healthcare LLC (Tarrytown, NY) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for interferon alfa-n3

Supplementary Protection Certificates for interferon alfa-n3

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
17/1999 Austria ➤ Try a Free Trial PRODUCT NAME: INTERFERON ALFACON-1
C0019 Belgium ➤ Try a Free Trial PRODUCT NAME: BETAFERON INTERFERON BETA-1B; REGISTRATION NO/DATE: EU/1/95/003/001 19951130
10/1996 Austria ➤ Try a Free Trial PRODUCT NAME: BETAFERON - INTERFERON BETA-1B
C0024 Belgium ➤ Try a Free Trial PRODUCT NAME: INTERFERON ALFACON-1; REGISTRATION NO/DATE: EU/1/98/O87/001 19990201
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Farmers Insurance
Chinese Patent Office
McKinsey
QuintilesIMS
US Army
Moodys
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.